Smith & Nephew (LON:SN) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Smith & Nephew plc (LON:SN - Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,094.26 ($14.79) and traded as high as GBX 1,361 ($18.40). Smith & Nephew shares last traded at GBX 1,345.50 ($18.19), with a volume of 1,841,468 shares.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on SN. JPMorgan Chase & Co. increased their price objective on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research report on Wednesday, August 6th. Berenberg Bank increased their price objective on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a "hold" rating in a research report on Thursday, August 7th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research report on Wednesday, August 6th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Price Performance

The business has a 50-day moving average price of GBX 1,180.15 and a 200 day moving average price of GBX 1,102.83. The company has a market cap of £15.16 billion, a price-to-earnings ratio of 49.79, a P/E/G ratio of 0.46 and a beta of 0.62. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22.

Insider Buying and Selling at Smith & Nephew

In other news, insider David King bought 2,800 shares of the business's stock in a transaction on Monday, August 18th. The shares were bought at an average cost of GBX 3,631 per share, with a total value of £101,668. Also, insider Deepak Nath sold 18,007 shares of the business's stock in a transaction on Monday, August 18th. The shares were sold at an average price of GBX 1,351, for a total transaction of £243,274.57. 0.19% of the stock is owned by insiders.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.